SCHEMBL81571

SCHEMBL81571

OCCCc1cccc(-c2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 1/20 0.49
AGXT P21549 1/20 0.48
LTA4H P09960 1/20 0.47
EPHX2 P34913 1/20 0.47
PRKCI P41743 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
GPR84 Q9NQS5 1/20 0.46
CYP4F2 P78329 3/20 0.45
CYP4A11 Q02928 3/20 0.45
IGF1R P08069 1/20 0.44
ALOX15 P16050 1/20 0.44
GGPS1 O95749 2/20 0.44
AOC3 Q16853 2/20 0.44
BCL2 P10415 1/20 0.42
IDH1 O75874 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3231456 0.98 ACMSD (0.47) ACMSDAGXTLTA4HEPHX2PRKCI
SCHEMBL27988774 0.94 CYP4F2 (0.49) ACMSDAGXTLTA4HEPHX2PRKCI
SCHEMBL3705276 0.92 BCHE (0.48) ACMSDAGXTPRKCITDP1GPR84
SCHEMBL5865105 0.88 TDP1 (0.62) ACMSDAGXTPRKCITDP1GPR84
Biphenyl SCHEMBL27528312 0.87 TDP1 (0.61) LTA4HEPHX2TDP1IGF1RALOX15
SCHEMBL19226923 0.86 GRIN2D (0.46) AGXTLTA4HEPHX2TDP1IGF1R
SCHEMBL5362418 0.85 AGXT (0.54) ACMSDAGXTPRKCICYP4F2CYP4A11
SCHEMBL612967 0.85 PTGES (0.47) ACMSDLTA4HEPHX2TDP1CYP4F2
SCHEMBL378731 0.85 HSD17B1 (0.52) ACMSDCYP4F2CYP4A11
SCHEMBL29618101 0.83 SIGMAR1 (0.52) AGXTIGF1RALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102146020-B Method for synthesizing 1,3-diphenyl-1-propanol compound UNIV JILIN 2013-09-18 CN claimed
CN-102146020-A Method for synthesizing 1,3-diphenyl-1-propanol compound UNIV JILIN 2011-08-10 CN claimed
CN-119285657-A Method for synthesizing alkyl borate compound by taking allyl alcohol as substrate 河南大学 2025-01-10 CN disclosed
CN-108117534-B Benzo-oxygenated aliphatic cyclomethylamines 华东理工大学 2021-02-05 CN disclosed
US-10829464-B2 Benzoheterocyclic alkylamine compounds and use thereof EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2020-11-10 US disclosed
CN-108084125-B Benzoheterocyclylalkylamines and their use 华东理工大学 2020-08-18 CN disclosed
US-20190315703-A1 BENZOHETEROCYCLIC ALKYLAMINE COMPOUNDS AND USE THEREOF EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-10-17 US disclosed
EP-3546454-A1 BENZOHETEROCYCLYL ALKYLAMINE COMPOUND AND USE THEREOF East China University of Science and Technology (CN) 2019-10-02 EP disclosed
EP-2168944-B1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2016-05-11 EP disclosed
EP-2168944-B1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2016-05-11 EP disclosed
CN-102146020-B Method for synthesizing 1,3-diphenyl-1-propanol compound UNIV JILIN 2013-09-18 CN disclosed
US-20030134841-A1 Succinoylamino lactams as inhibitors of A-beta protein production OLSON RICHARD E (US) 2003-07-17 US disclosed
US-20020159947-A1 Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging LANTHEUS MEDICAL IMAGING, INC. 2002-10-31 US disclosed
US-6331408-B1 CONTACTING A POTENTIAL INHIBITOR OF BETA-AMYLOID PRODUCTION AND TAGGED INHIBITOR OF BETA-AMYLOID PRODUCTION WITH AT MACROMOLECULE INVOLVED IN PROCESSING OF AMYLOID PRECURSOR PROTEIN; SEPARATING TAGGED INHIBITOR, DETERMINING BRISTOL-MYERS SQUIBB PHARMA COMPANY 2001-12-18 US disclosed
WO-2001087354-A2 USE OF SMALL MOLECULE RADIOLIGANDS FOR DIAGNOSTIC IMAGING BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-11-22 WO disclosed
EP-1129355-A1 USE OF RADIOLIGANDS TO SCREEN INHIBITORS OF AMYLOID-BETA PEPTIDE PRODUCTION Du Pont Pharmaceuticals Company (US) 2001-09-05 EP disclosed
EP-1102752-A1 SUCCINOYLAMINO LACTAMS AS INHIBITORS OF A BETA PROTEIN PRODUCTION Du Pont Pharmaceuticals Company (US) 2001-05-30 EP disclosed
WO-2000028331-A1 USE OF RADIOLIGANDS TO SCREEN INHIBITORS OF AMYLOID-BETA PEPTIDE PRODUCTION DU PONT PHARMACEUTICALS COMPANY (US) 2000-05-18 WO disclosed
WO-2000007995-A1 SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION DU PONT PHARMACEUTICALS COMPANY (US) 2000-02-17 WO disclosed
CN-1106003-A Inhibitors of microsomal triglyceride transfer protein and method BRISTOL MYERS SQIUBB COMPANY (US) 1995-08-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829464-B2 Benzoheterocyclic alkylamine compounds and use thereof AADAC, AAAS, NISCH ACMSD 71/4885AGXT 920/4885LTA4H 123/4885
US-20020159947-A1 Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging APP, BACE1, BACE2 ACMSD 4339/4885AGXT 2091/4885LTA4H 2678/4885
US-20190315703-A1 BENZOHETEROCYCLIC ALKYLAMINE COMPOUNDS AND USE THEREOF AADAC, AAAS, NISCH ACMSD 71/4885AGXT 920/4885LTA4H 123/4885
US-20030134841-A1 Succinoylamino lactams as inhibitors of A-beta protein production APH1A, BACE1, APP ACMSD 571/4885AGXT 355/4885LTA4H 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.